Skip to main content

An open comparative study of dispersible piroxicam versus soluble acetylsalicylic acid for the treatment of osteoarticular painful attack during sickle cell crisis

Buy Article:

$43.00 plus tax (Refund Policy)


We compared the efficacy and tolerability of oral piroxicam 1 mg/kg/day with soluble aspirin given at 100 mg/kg/day taken four-hourly in 58 patients with sickle cell anaemia and severe ostcoarticular painful attacks requiring hospitalization in a randomized, paralleled study. Main investigational criteria were pain relief, limitation of movement, fever, and insomnia or agitation. Both groups were well-matched at the commencement of therapy but most patients on piroxicam showed remarkable and significant pain relief and improvement in other parameters within 24 h. Unwanted effects were absent in the piroxicam-treated group whereas those treated with aspirin experienced nausea and vomiting. There were no significant changes in liver function tests with both forms of treatment. Oral piroxicam is an effective and safe treatment in the management of the osteoarticular painful crisis in sickle cell anaemia. It might prevent the use of parenteral analgesics and hospitalization and reduce the loss of school hours in patients who are being treated for bone pain crises that characterize sickle cell anaemia.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: nonsteroidal anti-inflammatory drugs; piroxicam; sickle cell anaemia

Document Type: Research Article

Affiliations: 1: Department of Paediatrics, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria 2: Department of Surgery, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria 3: Medical Department, Pfizer Products Plc, Ikeja, Lagos, Nigeria

Publication date: 2000-02-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more